These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 9521099)
1. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex. De Simone G; Lombardi A; Galdiero S; Nastri F; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V Protein Sci; 1998 Feb; 7(2):243-53. PubMed ID: 9521099 [TBL] [Abstract][Full Text] [Related]
2. The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode. Lombardi A; De Simone G; Nastri F; Galdiero S; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V Protein Sci; 1999 Jan; 8(1):91-5. PubMed ID: 10210187 [TBL] [Abstract][Full Text] [Related]
3. Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors. Lombardi A; Nastri F; Della Morte R; Rossi A; De Rosa A; Staiano N; Pedone C; Pavone V J Med Chem; 1996 May; 39(10):2008-17. PubMed ID: 8642559 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6. Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424 [TBL] [Abstract][Full Text] [Related]
5. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures. Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407 [TBL] [Abstract][Full Text] [Related]
6. From natural to synthetic multisite thrombin inhibitors. Lombardi A; De Simone G; Galdiero S; Staiano N; Nastri F; Pavone V Biopolymers; 1999; 51(1):19-39. PubMed ID: 10380350 [TBL] [Abstract][Full Text] [Related]
7. The methyl group of N(alpha)(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage. Friedrich R; Steinmetzer T; Huber R; Stürzebecher J; Bode W J Mol Biol; 2002 Mar; 316(4):869-74. PubMed ID: 11884127 [TBL] [Abstract][Full Text] [Related]
8. Refined structure of the hirudin-thrombin complex. Rydel TJ; Tulinsky A; Bode W; Huber R J Mol Biol; 1991 Sep; 221(2):583-601. PubMed ID: 1920434 [TBL] [Abstract][Full Text] [Related]
9. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors. Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244 [TBL] [Abstract][Full Text] [Related]
11. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study. Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015 [TBL] [Abstract][Full Text] [Related]
12. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin. Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394 [TBL] [Abstract][Full Text] [Related]
13. The ornithodorin-thrombin crystal structure, a key to the TAP enigma? van de Locht A; Stubbs MT; Bode W; Friedrich T; Bollschweiler C; Höffken W; Huber R EMBO J; 1996 Nov; 15(22):6011-7. PubMed ID: 8947023 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin. Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149 [TBL] [Abstract][Full Text] [Related]
15. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker. Slon-Usakiewicz JJ; Purisima E; Tsuda Y; Sulea T; Pedyczak A; Féthière J; Cygler M; Konishi Y Biochemistry; 1997 Nov; 36(44):13494-502. PubMed ID: 9354617 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids. De Filippis V; Quarzago D; Vindigni A; Di Cera E; Fontana A Biochemistry; 1998 Sep; 37(39):13507-15. PubMed ID: 9753436 [TBL] [Abstract][Full Text] [Related]
18. Rational design and selection of bivalent peptide ligands of thrombin incorporating P4-P1 tetrapeptide sequences: from good substrates to potent inhibitors. Su Z; Vinogradova A; Koutychenko A; Tolkatchev D; Ni F Protein Eng Des Sel; 2004 Aug; 17(8):647-57. PubMed ID: 15358856 [TBL] [Abstract][Full Text] [Related]
19. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor. Chirgadze NY; Sall DJ; Klimkowski VJ; Clawson DK; Briggs SL; Hermann R; Smith GF; Gifford-Moore DS; Wery JP Protein Sci; 1997 Jul; 6(7):1412-7. PubMed ID: 9232642 [TBL] [Abstract][Full Text] [Related]
20. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis. Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]